Opinion

Published in:
Volume 11 / Year 2022 / Issue 1

Biosimilarity is not a transitive property: implication for interchangeability, naming and pharmacovigilance

Author(s):

Abstract: Current regulations do not require a given biosimilar to remain similar to its reference biological over time. However, two products that were initially deemed biosimilar or interchangeable could each… Read More »

Go Back Print